BioInvent (BOVNF) Implements a Rights Issue of Approx. SEK 22 Million  
6/19/2013 10:51:10 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LUND, Sweden--(BUSINESS WIRE)--Not for release, or for publication or distribution, directly or indirectly in or into the United States, Australia, Hong Kong, Canada, Japan, New Zeeland or South Africa. BioInvent International AB (OMXS: BINV). The Board of Directors of BioInvent has resolved, by virtue of the authorisation from the Annual General Meeting, to conduct a rights issue of approximately SEK 22 million with pre-emptive right for the shareholders of the company. The purpose of the rights issue is to strengthen the company’s financial position and to increase the commercial flexibility.

Help employers find you! Check out all the jobs and post your resume.